Radiobromine and radioiodine for medical applications

References

1. Gribble, G. W.: Biological activity of recently discovered halogenated marine natural products. Mar. Drugs 13(7), 4044 (2015).10.3390/md13074044Suche in Google Scholar PubMed PubMed Central

2. Wagner, C., El Omari, M., Konig, G. M.: Biohalogenation: nature’s way to synthesize halogenated metabolites. J. Nat. Prod. 72(3), 540 (2009).10.1021/np800651mSuche in Google Scholar PubMed

3. Clark, T., Hennemann, M., Murray, J. S., Politzer, P.: Halogen bonding: the sigma-hole. J. Mol. Model 13(2), 291 (2007).10.1007/s00894-006-0130-2Suche in Google Scholar PubMed

4. Politzer, P., Murray, J. S., Clark, T.: Halogen bonding: an electrostatically-driven highly directional noncovalent interaction. Phys. Chem. Chem. Phys. 12(28), 7748 (2010).10.1039/c004189kSuche in Google Scholar PubMed

5. Scholfield, M. R., Zanden, C. M., Carter, M., Ho, P. S.: Halogen bonding (X-bonding): a biological perspective. Protein Sci. 22(2), 139 (2013).10.1002/pro.2201Suche in Google Scholar PubMed PubMed Central

6. Rowland, D. J., McCarthy, T. J., Welch, M. J.: Radiobromine for imaging and therapy. In: M. J. Welch, C. S. Redvanly (Eds.), Handbook of Radiopharmaceuticals: Radiochemistry and Applications (2003), John Wiley & Sons, Hoboken, NJ, USA, p. 441.10.1002/0470846380.ch14Suche in Google Scholar

7. Glaser, M., Luthra, S. K., Brady, F.: Applications of positron-emitting halogens in PET oncology (Review). Int. J. Oncol. 22(2), 253 (2003).10.3892/ijo.22.2.253Suche in Google Scholar

8. Adam, M. J., Wilbur, D. S.: Radiohalogens for imaging and therapy. Chem. Soc. Rev. 34(2), 153 (2005).10.1039/b313872kSuche in Google Scholar PubMed

9. Mason, N. S., Mathis, C. A.: Radiohalogens for PET imaging. In: D. L. Bailey, D. W. Townsend, P. E. Valk, M. N. Maisey (Eds.), Positron Emission Tomopgrphay (2003), Springer-Verlag, London, p. 217.Suche in Google Scholar

10. Wilbur, D. S.: Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjug. Chem. 3(6), 433 (1992).10.1021/bc00018a001Suche in Google Scholar PubMed

11. Adam, M. J.: Radiohalogenated carbohydrates for use in PET and SPECT. J. Labelled Comp. Rad. 45(2), 167 (2002).10.1002/jlcr.548Suche in Google Scholar

12. Weibe, L. I.: Radiohalogenated nitroimidazoles for single-photon scintigraphic imaging of hypoxic tissues. In: H.-J. Machulla (Eds.), Imaging of Hypoxia Tracer Developments (1999), Springer, Netherlands, p. 155.10.1007/978-94-017-1828-8_9Suche in Google Scholar

13. McConathy, J., Yu, W., Jarkas, N., Seo, W., Schuster, D. M., Goodman, M. M.: Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. Med. Res. Rev. 32(4), 868 (2012).10.1002/med.20250Suche in Google Scholar

14. Goodman, M. M., Yu, W., Jarkas, N.: Synthesis and biological properties of radiohalogenated alpha,alpha-disubstituted amino acids for PET and SPECT imaging of amino acid transporters (AATs). J. Labelled Comp. Radiopharm. 61(3), 272 (2018).10.1002/jlcr.3584Suche in Google Scholar

15. Rossin, R.: Radiolabeled nanoplatforms: imaging hot bullets hitting their target. In: X. Chen (Eds.), Nanoplatform-Based Molecular Imaging (2011), John Wiley & Sons, p. 399.10.1002/9780470767047.ch17Suche in Google Scholar

16. Stöcklin, G.: Bromine-77 and Iodine-123 radiopharmaceuticals. Int. J. Appl. Radiat. Isot. 28, 131 (1977).10.1016/B978-0-08-021344-6.50019-7Suche in Google Scholar

17. Bourguignon, M. H., Pauwels, E. K. J., Loch, C., Maziere, B.: Iodine-123 labelled radiopharmaceuticals and single-photon emission tomography: A natural liaison. Eur. J. Nucl. Med. 24(3), 331 (1997).10.1007/BF01728774Suche in Google Scholar

18. Maziere, B., Loc’h, C.: Use of bromine-76 and iodine-123 radiohalogenated tracers in the drug development process. Curr. Pharm. Des. 7(18), 1931 (2001).10.2174/1381612013396844Suche in Google Scholar

19. Koehler, L., Gagnon, K., McQuarrie, S., Wuest, F.: Iodine-124: a promising positron emitter for organic PET chemistry. Molecules 15(4), 2686 (2010).10.3390/molecules15042686Suche in Google Scholar

20. Chacko, A. M., Divgi, C. R.: Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography. Med. Chem. 7(5), 395 (2011).10.2174/157340611796799221Suche in Google Scholar

21. Mathis, C. A., Sargent, T., Shulgin, A. T.: Iodine-122-labeled amphetamine derivative with potential for pet brain blood-flow studies. J. Nucl. Med. 26(11), 1295 (1985).Suche in Google Scholar

22. Lagunas-Solar, M. C., Carvacho, O. F., Harris, L. J., Mathis, C. A.: Cyclotron production of Xe-122(20.1 H)-]I-122 (Beta + 77-Percent Ec 23-Percent 3.6 Min) for positron emission tomography – current methods and potential developments. Appl. Radiat. Isot. 37(8), 835 (1986).10.1016/0883-2889(86)90279-0Suche in Google Scholar

23. Tarkanyi, F., Qaim, S. M., Stocklin, G., Sajjad, M., Lambrecht, R. M.: Nuclear-reaction cross-sections relevant to the production of the Xe-122 → I-122 generator system using highly enriched Xe-124 and a medium-sized cyclotron. Appl. Radiat. Isot. 42(3), 229 (1991).10.1016/0883-2889(91)90081-BSuche in Google Scholar

24. Gambhir, S. S.: Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2(9), 683 (2002).10.1038/nrc882Suche in Google Scholar

25. Tai, Y. F., Piccini, P.: Applications of positron emission tomography (PET) in neurology. J. Neurol. Neurosurg. Psychiatry 75(5), 669 (2004).10.1142/9781860948961_0014Suche in Google Scholar

26. Belov, V. V., Bonab, A. A., Fischman, A. J., Heartlein, M., Calias, P., Papisov, M. I.: Iodine-124 as a label for pharmacological PET imaging. Mol. Pharm. 8(3), 736 (2011).10.1021/mp100358fSuche in Google Scholar

27. Fonge, H., Leyton, J. V.: Positron emission tomographic imaging of iodine-124 anti-prostate stem cell antigen-engineered antibody fragments in LAPC-9 tumor-bearing severe combined immunodeficiency mice. Mol. Imaging 12(3), 191 (2013).10.2310/7290.2012.00033Suche in Google Scholar

28. Lovqvist, A., Sundin, A., Ahlstrom, H., Carlsson, J., Lundqvist, H.: Pharmacokinetics and experimental PET imaging of a bromine-76-labeled monoclonal anti-CEA antibody. J. Nucl. Med. 38(3), 395 (1997).Suche in Google Scholar

29. Khalil, M. M., Tremoleda, J. L., Bayomy, T. B., Gsell, W.: Molecular SPECT imaging: an overview. Int. J. Mol. Imaging 2011, 796025 (2011).10.1155/2011/796025Suche in Google Scholar

30. Rosenthal, M. S., Cullom, J., Hawkins, W., Moore, S. C., Tsui, B. M., Yester, M.: Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. J. Nucl. Med. 36(8), 1489 (1995).Suche in Google Scholar

31. Dobrucki, L. W., Sinusas, A. J.: PET and SPECT in cardiovascular molecular imaging. Nat. Rev. Cardiol. 7(1), 38 (2010).10.1038/nrcardio.2009.201Suche in Google Scholar

32. Zipursky, R. B., Meyer, J. H., Verhoeff, N. P.: PET and SPECT imaging in psychiatric disorders. Can. J. Psychiatry 52(3), 146 (2007).10.1177/070674370705200303Suche in Google Scholar

33. Bonne, O., Krausz, Y., Lerer, B.: SPECT imaging in psychiatry. A review. Gen. Hosp. Psychiatry 14(5), 296 (1992).10.1016/0163-8343(92)90063-GSuche in Google Scholar

34. Kusic, Z., Becker, D. V., Saenger, E. L., Paras, P., Gartside, P., Wessler, T., Spaventi, S.: Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J. Nucl. Med. 31(4), 393 (1990).Suche in Google Scholar

35. Avram, A. M.: Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification. J. Nucl. Med. Technol. 42(3), 170 (2014).10.2967/jnumed.111.104133Suche in Google Scholar PubMed

36. Arnstein, N. B., Carey, J. E., Spaulding, S. A., Sisson, J. C.: Determination of I-131 diagnostic dose for imaging metastatic thyroid-cancer. J. Nucl. Med. 27(11), 1764 (1986).Suche in Google Scholar

37. Carlsson, J., Eriksson, V., Stenerlow, B., Lundqvist, H.: Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging 33(10), 1185 (2006).10.1007/s00259-006-0109-3Suche in Google Scholar PubMed PubMed Central

38. Haymart, M. R., Banerjee, M., Stewart, A. K., Koenig, R. J., Birkmeyer, J. D., Griggs, J. J.: Use of radioactive iodine for thyroid cancer. J. Am. Med. Assoc. 306(7), 721 (2011).10.1001/jama.2011.1139Suche in Google Scholar PubMed PubMed Central

39. Sisson, J. C., Yanik, G. A.: Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors. Semin. Nucl. Med. 42(3), 171 (2012).10.1053/j.semnuclmed.2011.11.004Suche in Google Scholar PubMed

40. Kelkar, S. S., Reineke, T. M.: Theranostics: combining imaging and therapy. Bioconjug. Chem. 22(10), 1879 (2011).10.1021/bc200151qSuche in Google Scholar PubMed

41. Srivastava, S. C.: Paving the way to personalized medicine: production of some promising theragnostic radionuclides at Brookhaven National Laboratory. Semin. Nucl. Med. 42(3), 151 (2012).10.1053/j.semnuclmed.2011.12.004Suche in Google Scholar PubMed

42. Sheikh, A., Polack, B., Rodriguez, Y., Kuker, R.: Nuclear molecular and theranostic imaging for differentiated thyroid cancer. Mol. Imaging Radionucl. Ther. 26, 50 (2017).10.4274/2017.26.suppl.06Suche in Google Scholar PubMed PubMed Central

43. Kassis, A. I.: The amazing world of Auger electrons. Int. J. Radiat. Biol. 80(11–12), 789 (2004).10.1080/09553000400017663Suche in Google Scholar PubMed

44. Kassis, A. I., Adelstein, S. J.: Radiobiologic principles in radionuclide therapy. J. Nucl. Med. 46(Suppl 1), 4S (2005).Suche in Google Scholar

45. Stepanek, J., Larsson, B., Weinreich, R.: Auger-electron spectra of radionuclides for therapy and diagnostics. Acta Oncol. 35, 863 (1996).10.3109/02841869609104038Suche in Google Scholar PubMed

46. Kassis, A. I., Adelstein, S. J., Haydock, C., Sastry, K. S. R., McElvany, K. D., Welch, M. J.: Lethality of Auger electrons from the decay of Bromine-77 in the DNA of mammalian cells. Radiat. Res. 90, 362 (1982).10.2307/3575714Suche in Google Scholar

47. Kassis, A. I., Wen, P. Y., Van den Abbeele, A. D., Baranowska-Kortylewicz, J., Makrigiorgos, G. M., Metz, K. R., Matalka, K. Z., Cook, C. U., Sahu, S. K., Black, P. M., Adelstein, S. J.: 5-[¹²⁵I]iodo-2′-deoxyuridine in the radiotherapy of brain tumors in rats. J. Nucl. Med. 39(7), 1148 (1998).Suche in Google Scholar

48. Panyutin, I. G., Neumann, R. D.: Sequence-specific DNA double-strand breaks induced by triplex forming ¹²⁵I labeled oligonucleotides. Nucleic Acids Res. 22(23), 4979 (1994).10.1093/nar/22.23.4979Suche in Google Scholar PubMed PubMed Central

49. Reed, M. W., Panyutin, I. G., Hamlin, D., Lucas, D. D., Wilbur, D. S.: Synthesis of ¹²⁵I-labeled oligonucleotides from tributylstannylbenzamide conjugates. Bioconjug. Chem. 8(2), 238 (1997).10.1021/bc970016nSuche in Google Scholar PubMed

50. DeSombre, E. R., Mease, R. C., Hughes, A., Harper, P. V., DeJesus, O. T., Friedman, A. M. Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancers. Cancer Res. 48, 899 (1988).10.2172/6347502Suche in Google Scholar PubMed

51. DeSombre, E. R., Shafii, B., Hanson, R. N., Kuivanen, P. C., Hughes, A.: Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Res. 52, 5752 (1992).Suche in Google Scholar

52. Ohashi, T., Yorozu, A., Saito, S., Momma, T., Toya, K., Nishiyama, T., Yamashita, S., Shiraishi, Y., Shigematsu, N.: Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation. Radiother. Oncol. 109(2), 241 (2013).10.1016/j.radonc.2013.09.022Suche in Google Scholar PubMed

53. Schwarz, S. B., Thon, N., Nikolajek, K., Niyazi, M., Tonn, J. C., Belka, C., Kreth, F. W.: Iodine-125 brachytherapy for brain tumours – a review. Radiat. Oncol. 7, 30 (2012).10.1186/1748-717X-7-30Suche in Google Scholar PubMed PubMed Central

54. Chen, K. Y., Xia, Y., Wang, H. N., Xiao, F. L., Xiang, G., Shen, F.: Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial. PLoS One 8(2), e57397 (2013).10.1371/journal.pone.0057397Suche in Google Scholar PubMed PubMed Central

55. Echegaray, J. J., Bechrakis, N. E., Singh, N., Bellerive, C., Singh, A. D.: Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose. Ocul. Oncol. Pathol. 3(3), 193 (2017).10.1159/000455872Suche in Google Scholar PubMed PubMed Central

56. Kahn, C. R., Roth, J.: Berson, Yalow, and the JCI: the agony and the ecstasy. J. Clin. Invest. 114(8), 1051 (2004).10.1172/JCI23316Suche in Google Scholar PubMed PubMed Central

57. Mirski, T., Bartoszcze, M., Bielawska-Drozd, A., Cieslik, P., Michalski, A. J., Niemcewicz, M., Kocik, J., Chomiczewski, K.: Review of methods used for identification of biothreat agents in environmental protection and human health aspects. Ann. Agric. Environ. Med. 21(2), 224 (2014).10.5604/1232-1966.1108581Suche in Google Scholar PubMed

58. Ma, Z., Du, L. P., Li, M. Y.: Toward fluorescent probes for g-protein-coupled receptors (GPCRs). J. Med. Chem. 57(20), 8187 (2014).10.1021/jm401823zSuche in Google Scholar PubMed

59. Qaim, S. M., Spahn, I.: Development of novel radionuclides for medical applications. J. Labelled Comp. Radiopharm. 61(3), 126 (2018).10.1002/jlcr.3578Suche in Google Scholar PubMed

60. Qaim, S. M.: Development of novel positron emitters for medical applications: nuclear and radiochemical aspects. Radiochim. Acta 99(10), 611 (2011).10.1524/ract.2011.1870Suche in Google Scholar

61. Coenen, H. H.: New radiohalogenation: an overview. In: P. H. Cox, S. J. Mather, C. B. Sampson, C. R. Lazarus (Eds.), Progress in Radiopharmacy. Developments in Nuclear Medicine (1986), Springer, Netherlands, p. 196.10.1007/978-94-009-4297-4_13Suche in Google Scholar

62. Coenen, H. H., Moerlein, S. M., Stöcklin, G.: No-carrier-added radiohalogenation methods with heavy halogens. Radiochim. Acta 34, 47 (1983).10.1524/ract.1983.34.12.47Suche in Google Scholar

63. Bolton, R.: Radiohalogen incorporation into organic systems. J. Labelled Comp. Radiopharm. 45(6), 485 (2002).10.1002/jlcr.575Suche in Google Scholar

64. Mason, N. S., Mathis, C. A.: Radiohalogens for PET Imaging. In: D. W. Townsend, P. E. Valk, M. N. Maisey (Eds.), Positron Emission Tomography (2005), Springer-Verlag, London, p. 203.10.1007/1-84628-007-9_9Suche in Google Scholar

65. Wilbur, D. S., Garcia, S. R., Adam, M. J., Ruth, T. J.: An evaluation of the introduction of stable nuclides of bromine into high specific activity radiobrominations. J. Labelled Comp. Radiopharm. 21(8), 767 (1984).10.1002/jlcr.2580210811Suche in Google Scholar

66. Moerlein, S. M., Beyer, W., Stocklin, G.: No-carrier-added radiobromination and radioiodination of aromatic rings using in situ generated peracetic-acid. J. Chem. Soc. Perkin Trans 1(4), 779 (1988).10.1039/P19880000779Suche in Google Scholar

67. Petzold, G., Coenen, H. H.: Chloramine-T for “no-carrier-added” labelling of aromatic biomolecules with bromine-75,77. J. Labelled Comp. Radiopharm. 18, 1319 (1981).10.1002/jlcr.2580180908Suche in Google Scholar

68. Mazaitis, J. K., Francis, B. E., Eckelman, W. C., Gibson, R. E., Reba, R. C., Barnes, J. W., Bentley, G. E., Grant, P. M., O’Brien, Jr., H. A.: No-carrier-added bromination of estrogens with Chloramine-T and Na Br-77. J. Labelled Comp. Radiopharm. 18(7), 1033 (1981).10.1002/jlcr.2580180714Suche in Google Scholar

69. Youfeng, H., Coenen, H. H., Petzold, G., Stöcklin, G.: A comparative study of radioiodination of simple aromatic compounds via N-halosuccinimides and Chloramine-T in TFAA. J. Labelled Comp. Radiopharm. 19, 807 (1982).10.1002/jlcr.2580190702Suche in Google Scholar

70. Wilbur, D. S., Bentley, G. E., O’Brien, H. A., Jr.: A rapid synthesis of A-ring bromine-77-labeled estrogens with high specific activity. J. Labelled Comp. Radiopharm. 18(11), 1693 (1981).10.1002/jlcr.2580181115Suche in Google Scholar

71. Coenen, H. H., Machulla, H-J., Stöcklin, G.: Practically carrier-free labelling of aromatic compounds with Bromine-77 via n-chloro-tetrafluorosuccinimide. J. Labelled Comp. Radiopharm. 16, 891 (1979).10.1002/jlcr.2580160612Suche in Google Scholar

72. Moore, D. H., Wolf, W.: Electrochemical radioiodination of estradiol. J. Labelled Comp. Radiopharm. 15, 443 (1978).10.1002/jlcr.2580150150Suche in Google Scholar

73. Wilbur, D. S.: [²¹¹At]Astatine-labeled compound stability: issues with released [²¹¹At]astatide and development of labeling reagents to increase stability. Curr. Radiopharm. 1, 144 (2008).10.2174/1874471010801030144Suche in Google Scholar

74. Kabalka, G. W., Varma, R. S.: The synthesis of radiolabeled compounds via organometallic intermediates. Tetrahedron 45, 6601 (1989).10.1016/S0040-4020(01)89131-6Suche in Google Scholar

75. Brown, I., Mitchell, J. S.: 6-[125I]-Iodo-2-methyl-1,4-naphthoquinol Bis(diammonium phosphate): a new potential anti-tumour drug. J Chem. Soc. Commun. 659 (1979).10.1039/c39790000659Suche in Google Scholar

76. Charleson, F. P., Flanagan, R. J., Synnes, E. I., Wiebe, L. I.: Rapid no carrier added radiolabeling using organomercury compounds. J. Labelled Comp. Radiopharm. 21(11-1), 1074 (1984).Suche in Google Scholar

77. Wilbur, D. S., Anderson, K. W., Stone, W. E., Svitra, Z., Rogers, R. S., O’Brien, H. A.: Regiospecific incorporation of radioiodine into aromatic rings via organosilanes. J. Labelled Comp. Radiopharm. 19, 1587 (1982).Suche in Google Scholar

78. Wilbur, D. S., Anderson, K. W., Stone, W. E., O’Brien, H. A., Jr. Radiohalogenation of nonactivated aromatic compounds via aryltrimethylsilyl intermediates. J. Labelled Comp. Radiopharm. 19(10), 1171 (1982).10.1002/jlcr.2580191008Suche in Google Scholar

79. Wilbur, D. S., Svitra, Z. V.: Organopentafluorosilicates: reagents for rapid and efficient incorporation of no-carrier-added radiobromine and radioiodine. J. Labelled Comp. Radiopharm. 20(5), 619 (1983).10.1002/jlcr.2580200508Suche in Google Scholar

80. Moerlein, S. M.: Use of Aryltrimethylgermanium substrates for facile aromatic chlorination, bromination, and iodination. J. Organ. Chem. 52, 664 (1987).10.1021/jo00380a031Suche in Google Scholar

81. Kabalka, G. W., Gooch, E. E., Hsu, H. C.: A convenient procedure for the synthesis of vinyl iodides via the reaction of iodine monochloride with vinylboronic acids. Syth. Commun. 11, 247 (1981).10.1080/00397918108061868Suche in Google Scholar

82. Kabalka, G. W., Gooch, E. E., Sastry, K. A. R.: Rapid and mild syntheses of radioiodine-labeled radiopharmaceuticals. J. Nucl. Med. 22, 908 (1981).Suche in Google Scholar

83. Kabalka, G. W., Gooch, E. E.: Synthesis of organic iodides via reaction of organoboranes with sodium iodide. J. Organ Chem. 46, 2582 (1981).10.1021/jo00325a030Suche in Google Scholar

84. Kabalka, G. W., Sastry, K. A. R., Pagni, P. G.: Rapid incorporation of radiobromine via the reaction of labeled sodium bromide with organoboranes. J. Radioanal. Chem. 74, 315 (1982).10.1007/BF02520383Suche in Google Scholar

85. Kabalka, G. W.: Incorporation of stable and radioactive isotopes via organoborane chemistry. Acc. Chem. Res. 17, 215 (1984).10.1021/ar00102a003Suche in Google Scholar

86. Adam, M. J., Ruth, T. J., Pate, B. D., Hall, L. D.: Site-Specific bromination of aromatic-compounds – a rapid method for radiobromine labeling. J. Chem. Soc. Chem. Commun. (11), 625 (1982).10.1039/c39820000625Suche in Google Scholar

87. Coleman, R. S., Seevers, R. H., Friedman, A. M.: Aromatic radiobromination without added carrier. J. Chem. Soc. Chem. Commun. 1982(21), 1276 (1982).10.1039/c39820001276Suche in Google Scholar

88. Ali, H., van Lier, J. E.: Synthesis of radiopharmaceuticals via organotin intermediates. Synthesis 4, 423 (1996).10.1055/s-1996-4250Suche in Google Scholar

89. Adam, M. J.: The demetallation reaction in radiohalogen labeling – synthesis of bromine and fluorine labeled compounds. Appl. Radiat. Isot. 37(8), 811 (1986).10.1016/0883-2889(86)90276-5Suche in Google Scholar

90. Moerlein, S. M., Mathis, C. A., Yano, Y.: Comparative-evaluation of electrophilic aromatic iododemetallation techniques for labeling radiopharmaceuticals with iodine-122. Appl. Radiat. Isot. 38(2), 85 (1987).10.1016/0883-2889(87)90001-3Suche in Google Scholar

91. Abou-Samra, A. B., Freeman, M., Juppner, H., Uneno, S., Segre, G. V.: Characterization of fully active biotinylated parathyroid hormone analogs. Application to fluorescence-activated cell sorting of parathyroid hormone receptor bearing cells. J. Biol. Chem. 265(1), 58 (1990).10.1016/S0021-9258(19)40194-4Suche in Google Scholar

92. Counsell, R. E., Ranade, V. V., Blair, R. J., Beierwaltes, W. H., Weinhold, P. A.: Tumor localizing agents. 9. Radioiodinated cholesterol. Steroids 16(3), 317 (1970).10.1002/jps.2600571005Suche in Google Scholar

93. Conn, J. W., Cohen, E. L., Beierwaltes, W. H., Herwig, K. R., Mcdonald, W. J., Morita, R.: Primary aldosteronism – photoscanning of tumors after administration of I-131-19-iodocholesterol. Arch. Intern. Med. 129(3), 417 (1972).10.1001/archinte.129.3.417Suche in Google Scholar

94. Maeda, M., Kojima, M., Ogawa, H., Nitta, K., Ito, T.: Homoallylic rearrangement of 19-Iodocholest-5-En-3beta-Ol – new adrenal scanning agent. Steroids 26(2), 241 (1975).10.1016/S0039-128X(75)80025-0Suche in Google Scholar

95. Kojima, M., Maeda, M.: Homoallylic rearrangement of 19-iodocholesterol. J. Chem. Commun. 47 (1975).10.1039/c3975000047aSuche in Google Scholar

96. Kojima, M., Maeda, M., Ogawa, H., Nitta, K., Ito, T.: Radioactive 6β-halogenomethyl-19-norcholest-5(10)-EN-3β-OL as an adrenal scanning agent. J. Labelled Comp. Radiopharm. 13, 227 (1977).Suche in Google Scholar

97. Kojima, M., Maeda, M., Ogawa, H., Nitta, K., Ito, T.: New adrenal-scanning agent. J. Nucl. Med. 16(7), 666 (1975).Suche in Google Scholar

98. Hochberg, R. B.: Iodine-125-labeled estradiol: a gamma-emitting analog of estradiol that binds to the estrogen receptor. Science 205, 1138 (1979).10.1126/science.472733Suche in Google Scholar

99. Symes, E. K., Coulson, W. F., Ralphs, D. N. L.: The synthesis of 16-alpha-[I-131]iodo-oestradiol and evaluation of its use as a radiotracer for estrogen-receptor positive breast-tumors. J. Steroid Biochem. 22(2), 155 (1985).10.1016/0022-4731(85)90107-4Suche in Google Scholar

100. Cummins, C. H.: Radiolabeled steroidal estrogens in cancer research. Steroids 58, 245 (1993).10.1016/0039-128X(93)90069-YSuche in Google Scholar

101. Katzenellenbogen, J. A.: Comparative binding affinitites of estrogen derivatives. Cancer Treat. Rep. 62, 1243 (1978).Suche in Google Scholar

102. Counsell, R. E., Buswink, A., Korn, N., Johnson, M., Ranade, V., Yu, T.: Radioiodinated estrogens and antiestrogens as potential imaging agents. In: K. M. J. Menon, J. R. Reel (Eds.), Steroid Hormone Action and Cancer (1976), Plenum Publishing Corporation, New York, NY, USA. p. 107.10.1007/978-1-4684-2601-4_9Suche in Google Scholar

103. Katzenellenbogen, J. A., Senderoff, S. G., McElvany, K. D., O’Brien, H. A., Welch, M. J.: 16a-[77Br]bromoestradiol-17β: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and induced mammary tumors. J. Nucl. Med. 22, 42 (1981).10.1097/00004728-198106000-00058Suche in Google Scholar

104. Senderoff, S. G., McElvany, K. D., Carlson, K. E., Heiman, D. F., Katzenellenbogen, J. A., Welch, M. J.: Methodology for the synthesis and specific activity determination of 16a-[⁷⁷Br]-bromoestradiol-17β and 16α-[⁷⁷Br]-11β-methoxyestradiol-17β, two estrogen receptor-binding radiopharmaceuticals. Int. J. Appl. Radiat. Isot. 33, 545 (1982).10.1016/0020-708X(82)90010-2Suche in Google Scholar

105. Ali, H., Rousseau, J., Gantchev, T. G., van Lier, J. E.: 2- and 4-Fluorinated 16α-[¹²⁵I]iodoestradiol derivatives: synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake. J. Med. Chem. 36, 4255 (1993).10.1021/jm00078a016Suche in Google Scholar

106. Ali, H., Rousseau, J., van Lier, J. E.: 7α-Methyl-and 11β-ethoxy-substitution of [¹²⁵I]-16α-iodoestradiol: effect on estrogen receptor-mediated target tissue uptake. J. Med. Chem. 36, 264 (1993).10.1021/jm00054a011Suche in Google Scholar

107. Flanagan, R. J., Charleson, F. P., Synnes, E. I., Wiebe, L. I., Theriault, Y. X., Nakashima, T. T.: Radiolabelling with organomercury compounds. Part I. The synthesis and structure of 6-halocholest-5-en-3β-ols. Can. J. Chem. 63, 2853 (1985).10.1139/v85-476Suche in Google Scholar

108. Flanagan, R. J., Charleson, F. P., Synnes, E. I., Wiebe, L. I.: Radiolabeling with organomercury compounds. 2. High specific activity synthesis of I-125 and iodine-131-6-iodocholest-5-en-3-beta-ol and its tissue distribution in rats. J. Nucl. Med. 27(7), 1165 (1986).Suche in Google Scholar

109. Hanson, R. N., Seitz, D. E., Botarro, J. C.: E-17α-[¹²⁵I]iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical. J. Nucl. Med. 23, 431 (1982).Suche in Google Scholar

110. Symes, E. K., Bishop, P. B., Coulson, W. F., Davies, A. G.: 17-alpha-Z-[I-125]iodovinyloestradiol and its 3-acetate – chemical synthesis and in vivo distribution studies in the rat – comparison of tissue accumulation and metabolic stability with 17-Alpha-e-[I-125]iodovinyl and 16-alpha-[I-125]iodo oestradiols. Biochem. Pharmacol. 44(4), 741 (1992).10.1016/0006-2952(92)90411-BSuche in Google Scholar

111. Ali, H., Rousseau, J., Paquette, B., Dube, C., Marko, B., van Lier, J. E.: Synthesis and biological properties of 7 alpha-cyano derivatives of the (17 alpha,20E/Z)-[I-125]iodovinyl- and 16 alpha-[I-125]iodo-estradiols. Steroids 68(14), 1189 (2003).10.1016/j.steroids.2003.09.005Suche in Google Scholar

112. Ali, H., Rousseau, J., van Lier, J. E.: Synthesis of A-ring fluorinated derivatives of (17α,20E/Z) – [¹²⁵I]iodovinylestradiols: effect on receptor binding and receptor-mediated target tissue uptake. J. Med. Chem. 38, 3061 (1993).10.1021/jm00073a004Suche in Google Scholar

113. Desombre, E. R., Hughes, A., Mease, R. C., Harper, P. V.: Comparison of the distribution of bromine-77-bromovinyl steroidal and triphenylethylene estrogens in the immature rat. J. Nucl. Med. 31(9), 1534 (1990).Suche in Google Scholar

114. Vaidyanathan, G.: Meta-iodobenzylguanidine and analogues: chemistry and biology. Q. J. Nucl. Med. Mol. Imaging 52(4), 351 (2008).Suche in Google Scholar

115. Wafelman, A. R., Konings, M. C. P., Hoefnagel, C. A., Maes, R. A. A., Beijnen, J. H.: Synthesis, radiolabeling and stability of radioiodinated m-iodobenzylguanidine, a review. Appl. Radiat. Isot. 45(10), 997 (1994).10.1016/0969-8043(94)90168-6Suche in Google Scholar

116. Agostini, D., Verberne, H. J., Hamon, M., Jacobson, A. F., Manrique, A.: Cardiac I-123-MIBG scintigraphy in heart failure. Q. J. Nucl. Med. Mol. Imaging 52(4), 369 (2008).10.1007/s00259-008-0976-xSuche in Google Scholar

117. Nakajima, K., Yoshita, M., Matsuo, S., Taki, J., Kinuya, S.: Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q. J. Nucl. Med. Mol. Imaging 52(4), 378 (2008).Suche in Google Scholar

118. Khan, M. U., Morse, M., Coleman, R. E.: Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors. Q. J. Nucl. Med. Mol. Imaging 52(4), 441 (2008).Suche in Google Scholar

119. Taggart, D., Dubois, S., Matthay, K. K.: Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma. Q. J. Nucl. Med. Mol. Imaging 52(4), 403 (2008).Suche in Google Scholar

120. Boubaker, A., Delaloye, A. B.: MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma. Q. J. Nucl. Med. Mol. Imaging 52(4), 388 (2008).Suche in Google Scholar

121. Havekes, B., Lai, E. W., Corssmit, P. M., Romijn, J. A., Timmers, H. J. L. M., Pacak, K.: Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q. J. Nucl. Med. Mol. Imaging 52(4), 419 (2008).Suche in Google Scholar

122. Wieland, D. M., Wu, J-l., Brown, L. E., Mangner, T. J., Swanson, D. P., Beierwaltes, W. H.: Radiolabled adrenergic neuron-blocking agents: adrenomedullary imaging with [¹³¹I]iodobenzylguanidine. J. Nucl. Med. 21, 349 (1980).Suche in Google Scholar

123. Wieland, D. M., Brown, L. E., Tobes, M. C., Rogers, W. L., Marsh, D. D., Mangner, T. J., Swanson, D. P., Beierwaltes, W. H.: Imaging the primate adrenal-medulla with [I-123] and [I-131] metalodobenzylguanidine – concise communication. J. Nucl. Med. 22(4), 358 (1981).Suche in Google Scholar

124. Horne, T., Hawkins, L. A., Britton, K. E., Granowska, M., Bouloux, P., Besser, G. M.: Imaging of pheochromocytoma and adrenal-medulla with I-123 meta-iodobenzyl guanidine. Nucl. Med. Commun. 5(12), 763 (1984).10.1097/00006231-198412000-00004Suche in Google Scholar

125. Mock, B. H., Weiner, R. E.: Simplified solid-state labeling of [¹²³I]m-iodobenzylguanidine. App. Radiat. Isot. 39, 939 (1988).10.1016/0883-2889(88)90036-6Suche in Google Scholar

126. Ott, R. J., Tait, D., Flower, M. A., Babich, J. W., Lambrecht, R. M.: Treatment planning for I-131 metaiodobenzylguanidine radiotherapy of neural crest tumors using I-124 metaiodobenzylguanidine positron emission tomography. Br. J. Radiol. 65(777), 787 (1992).10.1259/0007-1285-65-777-787Suche in Google Scholar

127. Moerlein, S. M., Hwang, D. R., Welch, M. J.: No-carrier-added radiobromination via cuprous chloride-assisted nucleophilic aromatic bromodeiodination. Appl. Radiat. Isot. 39(5), 369 (1988).10.1016/0883-2889(88)90064-0Suche in Google Scholar

128. Mertens, J., Vanryckeghem, W., Bossuyt, A.: High-yield preparation of I-123-N-isopropyl-para-iodoamphetamine (Iamp) in presence of Cu(I). J. Labelled Comp. Radiopharm. 22(1), 89 (1985).10.1002/jlcr.2580220112Suche in Google Scholar

129. Valette, H., Loch, C., Mardon, K., Bendriem, B., Merlet, P., Fuseau, C., Sabry, S., Raffel, D., Mazière, B., Syrota, A.: Bromine-76-metabromobenzylguanidine – a pet radiotracer for mapping sympathetic-nerves of the heart. J. Nucl. Med. 34(10), 1739 (1993).Suche in Google Scholar

130. Loch, C., Mardon, K., Valette, H., Brutesco, C., Merlet, P., Syrota, A., Maziere, B.: Preparation and pharmacological characterization of [Br-76]-meta-bromobenzylguanidine ([Br-76]Mbbg). Nucl. Med. Biol. 21(1), 49 (1994).10.1016/0969-8051(94)90128-7Suche in Google Scholar

131. Samnick, S., Bader, J. B., Muller, M., Chapot, C., Richter, S., Schaefer, A., Sax, B., Kirsch, C. M.: Improved labelling of no-carrier-added I-123-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias. Nucl. Med. Commun. 20(6), 537 (1999).10.1097/00006231-199906000-00008Suche in Google Scholar

132. Prabhakar, G., Mehra, K. S., Ramamoorthy, N., Chattopadhyay, S., Oommen, R., Narasimhan, S., Nair, N. A., Gunasekaran, S.: Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II). Appl. Radiat. Isot. 50(6), 1011 (1999).10.1016/S0969-8043(98)00168-7Suche in Google Scholar

133. Johansson, A., Sandstrom, P., Ullen, A., Erlandsson, A., Sundstrom, B., Ahlstrom, K. R., Johansson, L., Hietala, S. O., Stigbrand, T.: Stability and immunoreactivity of the monoclonal anticytokeratin antibody TS1 after different degrees of iodination. Acta Oncol. 38(3), 329 (1999).10.1080/028418699431401Suche in Google Scholar

134. Robles, A. M., Balter, H. S., Oliver, P., Welling, M. M., Pauwels, E. K. J.: Improved radioiodination of biomolecules using exhaustive Chloramine-T oxidation. Nucl. Med. Biol. 28(8), 999 (2001).10.1016/S0969-8051(01)00261-XSuche in Google Scholar

135. Tran, L., Baars, J., Damen, C., Beijnen, J., Huitema, A.: Three spectroscopic techniques evaluated as a tool to study the effects of iodination of monoclonal antibodies, exemplified by rituximab. J. Pharm. Biomed. 56(3), 609 (2011).10.1016/j.jpba.2011.05.026Suche in Google Scholar

136. Visser, G. W., Klok, R. P., Gebbinck, J. W. K., ter Linden, T., van Dongen, G. A., Molthoff, C. F.: Optimal quality I-131-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN. J. Nucl. Med. 42(3), 509 (2001).Suche in Google Scholar

137. Regoeczi, E.: Methods of protein iodination. iodine-labeled plasma proteins. I. CRC Press, Inc., Boca Raton, Florida (1984).Suche in Google Scholar

138. Otsuka, F. L., Welch, M. J.: Methods to label monoclonal antibodies for use in tumor imaging. Nucl. Med. Biol. 14, 243 (1987).10.1016/0883-2897(87)90048-1Suche in Google Scholar

139. Knight, L., Krohn, K. A., Welch, M. J., Spomer, B., Hager, L. P.: ⁷⁷Br: a new protein label. Soc. Nucl. Med. 149 (1975).Suche in Google Scholar

140. McElvany, K. D., Barnes, J. W., Welch, M. J.: Characterization of bromine-77-labeled proteins prepared using myeloperoxidase. Int. J. Appl. Radiat. Isot. 31, 679 (1980).10.1016/0020-708X(80)90004-6Suche in Google Scholar

141. McElvany, K. D., Welch, M. J.: Characterization of bromine-77-labeled proteins prepared using bromoperoxidase. J. Nucl. Med. 21, 953 (1980).10.1016/0020-708X(80)90004-6Suche in Google Scholar

142. Lövqvist, A., Sundin, A., Ahlström, H., Carlsson, J., Lundqvist, H.: Pharmacokinetics and experimental pet imaging of a bromine-76-labeled monoclonal anti-CEA antibody. J. Nucl. Med. 38, 395 (1997).Suche in Google Scholar

143. Silberring, J., Dubin, A., Szybinski, Z., Golda, W.: Catalytic iodination of proteins and hormones by horse myeloperoxidase in solid-state. Eur. J. Nucl. Med. 1(2), 80 (1976).Suche in Google Scholar

144. Dubin, A., Silberring, J.: Catalytic iodination of proteins by horse myeloperoxidase in solid-state. Anal. Biochem 72(1–2), 372 (1976).10.1016/0003-2697(76)90544-3Suche in Google Scholar

145. Marchalonis, J. J.: An enzymic method for trace iodination of immunoglobulins and other proteins. Biochem J. 113(2), 299 (1969).10.1042/bj1130299Suche in Google Scholar

146. Thorell, J. I., Johansson, B. G.: Enzymatic iodination of polypeptides with I-125 to high specific activity. Biochim. Biophys. Acta 251(3), 363 (1971).10.1016/0005-2795(71)90123-1Suche in Google Scholar

147. Pommier, J., Sokoloff, L., Nunez, J.: Enzymatic iodination of protein – kinetics of iodine formation and protein iodination catalyzed by horseradish-peroxidase. Eur. J. Biochem. 38(3), 497 (1973).10.1111/j.1432-1033.1973.tb03085.xSuche in Google Scholar

148. Hylarides, M. D., Leon, A. A., Mettler Jr, F. A., Wilbur, D. S.: Synthesis of 1-bromoestradiol. J. Organ Chem. 49(15), 2744 (1984).10.1021/jo00189a019Suche in Google Scholar

149. Hylarides, M. D., Buksa, P. L., Mettler, F. A., Wilbur, D. S.: Radiobromination of the 1-position of estradiol using no-carrier-added bromine-77. J. Labelled Comp. Radiopharm. 22(5), 437 (1985).10.1002/jlcr.2580220504Suche in Google Scholar

150. Malmquist, M., Thorell, J. I.: Direct radioiodination of estradiol for a sensitive radioimmunoassay. J. Clin. Endocr. Metab. 49(4), 655 (1979).10.1210/jcem-49-4-655Suche in Google Scholar

151. Ali, H., Ghaffari, M. A., Vanlier, J. E.: Regioselective A-ring iodination of estradiol diacetates. J. Steroid Biochem. 28(1), 21 (1987).10.1016/0022-4731(87)90118-XSuche in Google Scholar

152. Kawai, K., Fujibayashi, Y., Saji, H., Konishi, J., Kubodera, A., Yokoyama, A.: Monoiodo-D-tyrosine, an artificial amino-acid radiopharmaceutical for selective measurement of membrane amino-acid-transport in the pancreas. Nucl. Med. Biol. 17(4), 369 (1990).10.1016/0883-2897(90)90103-8Suche in Google Scholar

153. Mairs, R. J., Gaze, M. N., Watson, D. G., Skellern, G. G., Constable, P., McKellar, K., Owens, J., Vaidyanathan, G., Zalutsky, M. R.: Carrier-free ¹³¹I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine. Nucl. Med. Commun. 15(4), 268 (1994).10.1097/00006231-199404000-00157Suche in Google Scholar

154. Mairs, R. J., Russell, J., Cunningham, S., O’Donoghue, J. A., Gaze, M. N., Owens, J., Vaidyanathan, G., Zalutsky, M. R.: Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [¹³¹I] meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma. Eur. J. Cancer 31, 576 (1995).10.1016/0959-8049(95)00052-KSuche in Google Scholar

155. Green, M., Lowe, J., Kadirvel, M., McMahon, A., Westwood, N., Chua, S., Brown, G.: Radiosynthesis of no-carrier-added meta-[I-124]iodobenzylguanidine for PET imaging of metastatic neuroblastoma. J. Radioanal. Nucl. Chem. 311(1), 727 (2017).10.1007/s10967-016-5073-1Suche in Google Scholar PubMed PubMed Central

156. Rossouw, D. D., Macheli, L.: Large-scale synthesis of no-carrier-added [I-123] mIBG, using two different stannylated precursors. J. Labelled Comp. Radiopharm. 52(11–12), 499 (2009).10.1002/jlcr.1668Suche in Google Scholar

157. Zhang, W., Curran, D. P.: Synthetic applications of fluorous solid-phase extraction (F-SPE). Tetrahedron 62(51), 11837 (2006).10.1016/j.tet.2006.08.051Suche in Google Scholar

158. Donovan, A., Forbes, J., Dorff, P., Schaffer, P., Babich, J., Valliant, J. F.: A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports. J. Am. Chem. Soc. 128(11), 3536 (2006).10.1021/ja0600375Suche in Google Scholar

159. Dzandzi, J. P. K., Vera, D. R. B., Valliant, J. F.: A hybrid solid-fluorous phase radioiodination and purification platform. J. Labelled Comp. Radiopharm. 57(9), 551 (2014).10.1002/jlcr.3214Suche in Google Scholar

160. Donovan, A. C., Valliant, J. F.: A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity. Nucl. Med. Biol. 35(7), 741 (2008).10.1016/j.nucmedbio.2008.07.006Suche in Google Scholar

161. Wang, G., Chen, Z. M., Wu, E. M., Wang, Y., Huang, H. Y.: A convenient method for the preparation of radioiodinated meta-iodobenzylguanidine at a no-carrier-added level. J. Labelled Comp. Radiopharm. 58(11–12), 442 (2015).10.1002/jlcr.3348Suche in Google Scholar

162. Machulla, H-J., Stöcklin, G., Kupfernagel, C., Freundlieb, C., Höck, A., Vyska, K., Feinendegen, LE.: Comparative evaluation of fatty acids labeled with C-11, CI-34m, Br-77, and I-123 for metabolic studies of the myocardium: concise communication. J. Nucl. Med. 19, 298 (1978).Suche in Google Scholar

163. Otto, C. A., Brown, L. E., Wieland, D. M., Beierwaltes, W. H.: Synthesis of ¹²⁵I-labeled 14-iodo-9-tetradecynoic acid. J. Labelled Comp. Radipharm. 18, 1347 (1981).10.1002/jlcr.2580180911Suche in Google Scholar

164. Goodman, M. M., Knapp Jr., F. F., Callahan, A. P., Ferren, L. A.: Synthesis and biological evaluation of 17-[¹³¹I]Iodo-9-telluraheptadecanoic acid, a potential myocardial imaging agent. J. Med. Chem. 25, 613 (1982).10.1021/jm00348a001Suche in Google Scholar

165. Coenen, H. H., Harmand, M.-F., Kloster, G., Stöcklin, G.: 15-(p-[⁷⁵Br]bromophenyl)pentadecanoic acid: pharmacokinetics and potential as heart agent. J. Nucl. Med. 22, 891 (1981).Suche in Google Scholar

166. Verbruggen, R. F.: Preparation of 15-(p-[¹²³I]Iodophenyl) pentadecanoic acid and 15-(p-[¹²³I]Iodophenyl)-3-methylpentadecanoic acid by means of Sn. Appl. Radiat. Isot. 39, 1097 (1988).10.1016/0883-2889(88)90148-7Suche in Google Scholar

167. Goodman, M. M., Kirsch, G., Knapp, Jr. F. F.: Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted α- and β-methyl-branched fatty acids. J. Med. Chem. 27, 390 (1984).10.1021/jm00369a027Suche in Google Scholar

168. Sinn, H., Maier-Borst, W., Elias, H.: An efficient method for routine production of o-iodohippuric acid labelled with ¹³¹I, ¹²⁵I or ¹²³I. Int. J. Appl. Radiat. Isot. 28, 809 (1977).10.1016/0020-708X(77)90122-3Suche in Google Scholar

169. Van Wyk, A. J., Bekker, P., Niemann, D., Roesch, H., Fourie, P. J., Haasbroek, F. J., Venter, S. S.: Development and bioevaluation of (o)-⁸²Br[⁷⁷Br]-bromohippuran. Int. J. Appl. Radiat. Isot. 34(7), 1019 (1983).10.1016/0020-708X(83)90085-6Suche in Google Scholar

170. van Aswegen, A., van Wyk, A. J., Roodt, J. P., Pieters, H., Herbst, C. P., Otto, A. C., Lötter, M. G., Haasbroek, F. J., Minnaar, P. C., Fourie, P. J.: Evaluation of (o)-[⁷⁷Br]bromohippuran as renal tubular function agent. Int. J. Appl. Radiat. Isot. 36(9), 727 (1985).10.1016/0020-708X(85)90044-4Suche in Google Scholar

171. De Jesus, O., Djermouni, B., Ache, H. J.: On the preparation of ^80mBr labelled biomolecules: solvent assisted labelling of hippuric acid via the CF₃^80mBr-KBrO₃ technique. Int. J. Appl. Radiat. Isot. 32, 681 (1981).10.1016/0020-708X(81)90012-0Suche in Google Scholar

172. Wilbur, D. S., Svitra, Z. V.: Electrophilic radiobrominations of hippuric acid: an example of the utility of aryltrimethylsilane intermediates. J. Labelled Comp. Radiopharm. 21(5), 415 (1984).10.1002/jlcr.2580210505Suche in Google Scholar

173. Hinkle, G. H., Basmadjian, G. P., Kirschner, A. S., Ice, R. D.: Kit preparation of radioiodinated ortho-iodohippuran. J. Pharm. Sci. 70(3), 312 (1981).10.1002/jps.2600700323Suche in Google Scholar

174. Seevers, R. H., Friedman, A. M.: [⁷⁷Br]Halothane: a radiobrominated anesthetic. Int. J. Appl. Radiat. Isot. 34, 1407 (1983).10.1016/0020-708X(83)90037-6Suche in Google Scholar

175. Heiss, W. D., Herholz, K.: Brain receptor imaging. J. Nucl. Med. 47(2), 302 (2006).Suche in Google Scholar

176. Beaulieu, J. M., Gainetdinov, R. R.: The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63(1), 182 (2011).10.1124/pr.110.002642Suche in Google Scholar

177. Jaber, M., Robinson, S. W., Missale, C., Caron, M. G.: Dopamine receptors and brain function. Neuropharmacology 35(11), 1503 (1996).10.1016/S0028-3908(96)00100-1Suche in Google Scholar

178. Sitte, H. H., Freissmuth, M.: Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol. Sci. 36(1), 41 (2015).10.1016/j.tips.2014.11.006Suche in Google Scholar PubMed PubMed Central

179. Sulzer, D., Sonders, M. S., Poulsen, N. W., Galli, A.: Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75(6), 406 (2005).10.1016/j.pneurobio.2005.04.003Suche in Google Scholar PubMed

180. Zezula, J., Cortes, R., Probst, A., Palacios, J. M.: Benzodiazepine receptor-sites in the human-brain – autoradiographic mapping. Neuroscience 25(3), 771 (1988).10.1016/0306-4522(88)90036-XSuche in Google Scholar

181. Nichols, D. E., Nichols, C. D.: Serotonin receptors. Chem. Rev. 108(5), 1614 (2008).10.1021/cr078224oSuche in Google Scholar

182. Murphy, D. L., Lerner, A., Rudnick, G., Lesch, K. P.: Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4(2), 109 (2004).10.1124/mi.4.2.8Suche in Google Scholar

183. Vyklicky, V., Korinek, M., Smejkalova, T., Balik, A., Krausova, B., Kaniakova, M., Lichnerova, K., Cerny, J., Krusek, J., Dittert, I., Horak, M., Vyklicky, L.: Structure, function, and pharmacology of NMDA receptor channels. Physiol. Res. 63, S191 (2014).10.33549/physiolres.932678Suche in Google Scholar

184. Danysz, W., Parsons, C. G.: Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev. 50(4), 597 (1998).Suche in Google Scholar

185. Rousseaux, C. G., Greene, S. F.: Sigma receptors [sigmaRs]: biology in normal and diseased states. J. Recept. Signal Transduct. Res. 1 (2015).10.3109/10799893.2015.1015737Suche in Google Scholar

186. Kuhl, D. E., Barrio, J. R., Huang, S. C., Selin, C., Ackermann, R. F., Lear, J. L., Wu, J. L., Lin, T. H., Phelps, M. E.: Quantifying local cerebral blood-flow by N-Isopropyl-P-(I-123)iodoamphetamine (IMP) tomography. J. Nucl. Med. 23(3), 196 (1982).Suche in Google Scholar

187. Sargent, T., 3rd, Kalbhen, D. A., Shulgin, A. T., Stauffer, H., Kusubov, N.: A potential new brain-scanning agent: 4-⁷⁷Br-2,5-dimethoxyphenylisoproplamine (4-Br-DPIA). J. Nucl. Med. 16(3), 243 (1975).Suche in Google Scholar

188. Sargent, T., Kalbhen, D. A., Shulgin, A. T., Braun, G., Stauffer, H., Kusubov, N.: In vivo human pharmacodynamics of the psychodysleptic 4-BR-2,5-dimethoxyphenylisopropylamine labelled with ‘BRor ‘BR. Neuropharmacology 14(3), 165 (1975).10.1016/0028-3908(75)90001-5Suche in Google Scholar

189. Coenen, H. H.: Synthesis of Br-77-labeled 2-(4-Bromo-2,5-Dimethoxyphenyl)-isopropylamine with high specific activity. J. Labelled Comp. Radiopharm. 18(5), 739 (1981).10.1002/jlcr.2580180516Suche in Google Scholar

190. Wang, S. S., Mathis, C. A., Peroutka, S. J.: R(−)-2,5-dimethoxy-4-77 bromoamphetamine [⁷⁷Br-R(-)DOB]: a novel radioligand which labels a 5-HT binding site subtype. Psychopharmacology (Berl) 94(3), 431 (1988).10.1007/BF00174703Suche in Google Scholar

191. Mathis, C. A., Shulgin, A. T., Sargent, T.: Synthesis of I-122 Labeled and I-125 labeled meta-dimethoxy-N,N-dimethyliodophenylisopropylamines. J. Labelled Comp. Radiopharm. 23(2), 115 (1986).10.1002/jlcr.2580230202Suche in Google Scholar

192. Friedman, A. M., Cheronis, J., Zalutsky, M., Cooper, M., Hoffman, P., Heller, A., et al. Preparation of Br-77 and Br-76 L-Dopa and 5-Hydroxytryptophan Analogs. J. Labelled Comp. Radiopharm. 16(1), 66 (1979).Suche in Google Scholar

193. Hu, F., Li, Y.: Radiobromine labeling of 3,4-dihydroxy-phenyl-L-alanine and distribution study in mouse brain. Nucl. Sci. Techol. 4(1), 51 (1993).Suche in Google Scholar

194. Fowler, J. S., MacGregor, R. R., Wolf, A. P.: Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals. J. Med. Chem. 19, 356 (1976).10.1021/jm00225a002Suche in Google Scholar PubMed

195. Moerlein, S. M., Laufer, P., Stöcklin, G., Pawlik, G., Wienhard, K., Heiss, W-D.: Evaluation of ⁷⁵Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography. Eur. J. Nucl. Med. 12, 211 (1986).10.1007/BF00256924Suche in Google Scholar PubMed

196. Moerlein, S. M., Mathis, C. A., Brennan, K. M., Budinger, T. F.: Synthesis and in vivo evaluation of ¹²²I- and ¹³¹I-labelled iodoperidol, a potential agent for the tomographic assessment of cerebral perfusion. Int. J. Rad. Appl. Instrum. B 14(2), 91 (1987).10.1016/0883-2897(87)90137-1Suche in Google Scholar

197. Suehiro, M., Yokoi, F., Nozaki, T., Iwamoto, M.: No-carrier-added radiobromination via the gattermann reaction – synthesis of ⁷⁵Br-bromperidol and ⁷⁷Br-bromperidol. J. Labelled Comp. Radiopharm. 24(10), 1143 (1987).10.1002/jlcr.2580241002Suche in Google Scholar

198. Kulmala, H. K., Huang, C. C., Dinerstein, R. J., Freidman, A. M.: Specific in vivo binding of ⁷⁷Br-p-bromospiroperidol in rat brain: a potential tool for gamma ray imaging. Life Sci. 28, 1911 (1981).10.1016/0024-3205(81)90298-8Suche in Google Scholar

199. DeJesus, O. T., Friedman, A. M., Prasad, A., Revenaugh, J. R.: Preparation and purificaion of ⁷⁷Br-labelled p-bromospiroperidol suitable for in vivo dopamine receptor studies. J. Labelled Comp. Radiopharm. 20, 745 (1983).10.1002/jlcr.2580200609Suche in Google Scholar

200. Maziere, B., Loch, C., Hantraye, P., Guillon, R., Duquesnoy, N., Soussaline, F., Naquet, R., Comar, D., Mazière, M.: Br-76 bromospiroperidol – a new tool for quantitative invivo imaging of neuroleptic receptors. Life. Sci. 35(13), 1349 (1984).10.1016/0024-3205(84)90391-6Suche in Google Scholar

201. Dejesus, O. T., Vanmoffaert, G. J., Glock, D., Goldberg, L. I., Friedman, A. M.: Synthesis of a radiobrominated analog of Sch-23390, a Selective Dopamine D1/Da1 Antagonist. J. Labelled Comp. Radiopharm. 23(9), 919 (1986).10.1002/jlcr.2580230902Suche in Google Scholar

202. Kassiou, M., Loc’h, C., Bottlaender, M., Mardon, K., Ottaviani, M., Coulon, C., Katsifis, A., Maziere, B.: (+)-[(76) Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET. Nucl. Med. Biol. 29(3), 295 (2002).10.1016/S0969-8051(01)00306-7Suche in Google Scholar

203. Kassiou, M., Loc’h, C., Katsifis, A., Papazian, V., Mattner, F., Dikic, B., Maziere, B.: Radiosynthesis of bromine-76 and iodine-123 labelled enantiomers of A-69024: Radioligands for dopamine D1 receptor studies using PET and SPECT. J. Labelled Comp. Radiopharm. 43(4), 339 (2000).10.1002/(SICI)1099-1344(20000330)43:4<339::AID-JLCR321>3.0.CO;2-6Suche in Google Scholar

204. Loch, C., Muller, L., Ottaviani, M., Halldin, C., Farde, L., Maziere, B.: Synthesis of 2-Beta-carbomethoxy-3-Beta-(4-[Br-76]bromophenyl)tropane ([Br-76]Beta-Cbt), a pet tracer for in-vivo imaging of the dopamine uptake sites. J. Labelled Comp. Radiopharm. 36(4), 385 (1995).10.1002/jlcr.2580360412Suche in Google Scholar

205. Maziere, B., Loch, C., Muller, L., Halldin, C.: Br-76-Beta-Cbt, a pet tracer for investigating dopamine neuronal uptake. Nucl. Med. Biol. 22(8), 993 (1995).10.1016/0969-8051(95)02021-7Suche in Google Scholar

206. Loch, C., Halldin, C., Bottlaender, M., Swahn, C. G., Moresco, R. M., Maziere, M., Farde, L., Mazière, B.: Preparation of [Br-76]FLB 457 and [Br-76]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET. Nucl. Med. Biol. 23(6), 813 (1996).10.1016/0969-8051(96)00078-9Suche in Google Scholar

207. Maziere, B., Loch, C., Stulzaft, O., Hantraye, P., Ottaviani, M., Comar, D., Maziere, M.: [Br-76] bromolisuride – a new tool for quantitative invivo imaging of D-2 dopamine-receptors. Eur. J. Pharmacol. 127(3), 239 (1986).10.1016/0014-2999(86)90370-5Suche in Google Scholar

208. Delforge, J., Loch, C., Hantraye, P., Stulzaft, O., Khalilivarasteh, M., Maziere, M., Syrota, A., Mazière, B.: Kinetic-analysis of central [Br-76] bromolisuride binding to dopamine D2 receptors studied by PET. J. Cerebr. Blood. F. Met. 11(6), 914 (1991).10.1038/jcbfm.1991.156Suche in Google Scholar

209. Mathis, C. A., Enas, J. D., Hanrahan, S. M., Akgun, E.: Synthesis of I-123 and I-125 labeled 5-Iodo-6-nitroquipazine. J. Labelled Comp. Radiopharm. 34(10), 905 (1994).10.1002/jlcr.2580341003Suche in Google Scholar

210. Lundkvist, C., Loc’h, C., Halldin, C., Bottlaender, M., Ottaviani, M., Coulon, C., Fuseau, C., Mathis, C., Farde, L., Mazière, B.: Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter. Nucl. Med. Biol. 26(5), 501 (1999).10.1016/S0969-8051(99)00019-0Suche in Google Scholar

211. Strijckmans, V., Lee, K. S., Loch, C., Ottaviani, M., Zeeberg, B. R., Maziere, B.: Preparation and characterization of (R,S)-[Br-76]BrQNB: an analogue of QNB for PET. J. Labelled Comp. Radiopharm. 39(4), 339 (1997).10.1002/(SICI)1099-1344(199704)39:4<339::AID-JLCR969>3.0.CO;2-CSuche in Google Scholar

212. Strijckmans, V., Bottlaender, M., Luo, H. M., Ottaviani, M., McPherson, D. W., Loch, C., Fuseau, C., Knapp, F. F., Mazière, B.: Positron emission tomographic investigations of central muscarinic cholinergic receptors with three isomers of [Br-76]BrQNP. Eur. J. Nucl. Med. 24(5), 475 (1997).10.1007/s002590050078Suche in Google Scholar

213. Rzeszotarski, W. J., Eckelman, W. C., Francis, B. E., Simms, D. A., Gibson, R. E., Jagoda, E. M., Grissom, M. P., Eng, R. R., Conklin, J. J., Reba, R. C.: Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo[2.2.2]Oct-3-Yl alpha-hydroxy-alpha-(4-iodophenyl)-alpha-phenylacetate as potential radiopharmaceuticals. J. Med. Chem. 27(2), 156 (1984).10.1021/jm00368a009Suche in Google Scholar

214. Gibson, R. E., Weckstein, D. J., Jagoda, E. M., Rzeszotarski, W. J., Reba, R. C., Eckelman, W. C.: The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro. J. Nucl. Med. 25, 214 (1984).Suche in Google Scholar

215. Lee, K. S., He, X. S., Jones, D. W., Coppola, R., Gorey, J. G., Knable, M. B., deCosta, B. R., Rice, K. C., Weinberger, D. R.: An improved method for rapid and efficient radioiodination of iodine-123-IQNB. J. Nucl. Med. 37(12), 2021 (1996).Suche in Google Scholar

216. Kassiou, M., Loch, C., Strijckmans, V., Katsifis, A., Lambrecht, R. M., Maziere, M., Maziere, B.: Synthesis of [Br-76]4-bromodexetimide and [Br-76] 4-bromolevetimide – radiotracers for studying muscarinic cholinergic receptors using PET. J. Labelled Comp. Radiopharm. 36(3), 259 (1995).10.1002/jlcr.2580360308Suche in Google Scholar

217. Dumont, F., Slegers, G.: Synthesis of [Br-77] 5,7-dibromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid, a possible SPECT tracer for NMDA receptor studies. J. Labelled Comp. Radiopharm. 38(9), 795 (1996).10.1002/(SICI)1099-1344(199609)38:9<795::AID-JLCR891>3.0.CO;2-2Suche in Google Scholar

218. Owens, J., Tebbutt, A. A., McGregor, A. L., Kodama, K., Magar, S. S., Perlman, M. E., Robins, D. J., Durant, G. J., McCulloch, J.: Synthesis and binding characteristics of N-(1-naphthyl)-N′-(3-[I-125]-iodophenyl)-N′-methylguanidine ([I-125]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation. Nuclear Med. Biol. 27(6), 557 (2000).10.1016/S0969-8051(00)00102-5Suche in Google Scholar

219. Bressan, R. A., Erlandsson, K., Mulligan, R. S., Gunn, R. N., Cunningham, V. J., Owens, J., Cullum, I. D., Ell, P. J., Pilowsky, L. S.: A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [I-123]CNS 1261. Nucl. Med. Biol. 31(2), 155 (2004).10.1016/j.nucmedbio.2003.08.008Suche in Google Scholar

220. Scholl, H., Kloster, G., Stöcklin, G.: Bromine-75-Labeled 1,4-benzodiazepines: potential agents for the mapping of benzodiazepine receptors in vivo: concise communication. J. Nucl. Med. 24, 417 (1983).Suche in Google Scholar

221. Foged, C., Halldin, C., Loch, C., Maziere, B., Pauli, S., Maziere, M., Hansen, H. C., Suhara, T., Swahn, C. G., Karlsson, P., Farde, L.: Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography (PET). Eur. J. Nucl. Med. 24(10), 1261 (1997).10.1007/s002590050150Suche in Google Scholar

222. Zecca, L., Ferrario, P.: Synthesis and biodistribution of an I-123 labeled flunitrazepam derivative – a potential in vivo tracer for benzodiazepine receptors. Appl. Radiat. Isot. 39(4), 353 (1988).10.1016/0883-2889(88)90029-9Suche in Google Scholar

223. Rowland, D. J., Tu, Z., Xu, J., Ponde, D., Mach, R. H., Welch, M. J.: Synthesis and in vivo evaluation of 2 high-affinity ⁷⁶Br-labeled sigma2-receptor ligands. J. Nucl. Med. 47(6), 1041 (2006).Suche in Google Scholar

224. Carballo, M., Quiros, R. M.: To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients. J. Oncol. 2012, 707156 (2012).10.1155/2012/707156Suche in Google Scholar

225. Beierwaltes, W. H.: The history of the use of radioactive iodine. Semin. Nucl. Med. 9(3), 151 (1979).10.1016/S0001-2998(79)80023-9Suche in Google Scholar

226. Hertz, S., Roberts, A.: Radioactive iodine in the study of thyroid physiology. 7. The use of radioactive iodine therapy in hyperthyroidism. J. Am. Med. Assoc. 131(2), 81 (1946).10.1001/jama.1946.02870190005002Suche in Google Scholar PubMed

227. Chapman, E. M., Evans, R. D.: The treatment of hyperthyroidism with radioactive iodine. J. Am Med. Assoc. 131(2), 86 (1946).10.1001/jama.1946.02870190010003Suche in Google Scholar PubMed

228. Milanesi, A., Brent, G. A.: Iodine and thyroid hormone synthesis, metabolism, and action. In: J. Collins (Ed.), Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals, Academic Press. p. 143 (2017).10.1016/B978-0-12-802168-2.00012-9Suche in Google Scholar

229. Korn, N., Nordblom, G., Floyd, E., Counsell, R. E.: Potential organ- or tumor-imaging agents XX: ovarian imaging with 19-radioiodinated cholesterol. J. Pharm. Sci. 69(9), 1014 (1980).10.1002/jps.2600690908Suche in Google Scholar PubMed

230. Harapanhalli, R. S., Roy, A. M., Adelstein, S. J., Kassis, A. I.: [I-125/I-127/I-131] iodorhodamine: synthesis, cellular localization, and biodistribution in athymic mice bearing human tumor xenografts and comparison with [Tc-99m]Hexakis(2-methoxyisobutylisonitrile). J. Med. Chem. 41(12), 2111 (1998).10.1021/jm970691iSuche in Google Scholar

231. Ho, N.-h., Tumeh, P. C., Kassis, A. I.: Synthesis and biologic studies of iodinated (¹²⁵I/¹²⁷I) ethidium. Nucl. Med. Biol. 28(8), 983 (2001).10.1016/S0969-8051(01)00266-9Suche in Google Scholar

232. Larose, J. H., Whitakert, R. H., Reba, R. C.: Radioiodinated toluidine blue: an unsatisfactory scanning agent. J. Nucl. Med. 11, 731 (1970).10.1097/00007611-196911000-00058Suche in Google Scholar

233. Buchegger, F., Adamer, F., Schaffland, A. O., Kosinski, M., Grannavel, C., Dupertuis, Y. M., de Tribolet, N., Mach, J. P., Delaloye, A. B.: Highly efficient DNA incorporation of intratumourally injected [I-125]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts. Int. J. Cancer 110(1), 145 (2004).10.1002/ijc.20112Suche in Google Scholar

234. Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G., Langen, K. J., Piers, D. A.: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J. Nucl. Med. 42(3), 432 (2001).Suche in Google Scholar

235. Langen, K. J., Broer, S.: Molecular transport mechanisms of radiolabeled amino acids for PET and SPECT. J. Nucl. Med. 45(9), 1435 (2004).Suche in Google Scholar

236. Huang, C., McConathy, J.: Radiolabeled amino acids for oncologic imaging. J. Nucl. Med. 54(7), 1007 (2013).10.2967/jnumed.112.113100Suche in Google Scholar

237. Romero-Garcia, S., Lopez-Gonzalez, J. S., Baez-Viveros, J. L., Aguilar-Cazares, D., Prado-Garcia, H.: Tumor cell metabolism an integral view. Cancer Biol. Ther. 12(11), 939 (2011).10.4161/cbt.12.11.18140Suche in Google Scholar

238. Thakur, M. L., Leeper, D. B., Rowley, R., Park, C. H.: Radioiodinated rhodamine-123: preparation and preliminary evaluation as an agent for tumor scintigraphy. Nucl. Med. Biol. 15, 517 (1988).10.1016/S0969-8051(88)80008-8Suche in Google Scholar

239. Ercan, M. T.: A simple method of labeling bromphenol blue with Br-77. Int. J. Appl. Radiat. Isot. 32(6), 441 (1981).10.1016/S0020-708X(81)81013-7Suche in Google Scholar

240. Senekowitsch, R., Mollenstadt, S.: Prolonged retention of Br-77 labeled bromphenol blue in tumor-tissue. Int. J. Nucl. Med. Biol. 11(1), 60 (1984).10.1016/0047-0740(84)90034-2Suche in Google Scholar

241. Gobuty, A. H., Spicer, J. A., Dressler, R. L.: Preparation of a radiobrominated fluorescein for liver scanning. J. Labelled Comp. Radiopharm. 17(1), 73 (1980).10.1002/jlcr.2580170108Suche in Google Scholar

242. Reiffers, S., Lambrecht, R. M., Wolf, A. P., Christman, D. R., Ansari, A. N., Atkins, H. L.: Cyclotron isotopes and radiopharmaceuticals-XXXIII. Synthesis and structural effects of selective biliary excretion of halogenated indotricarbocyanines. Int. J. Appl. Radiat. Isot. 34, 1383 (1983).10.1016/0020-708X(83)90032-7Suche in Google Scholar

243. Abrams, D. N., Lee, Y. W., Knaus, E. E., Wiebe, L. I.: Synthesis of [6-³⁶Cl]chlorouracil, [6-⁸²Br]bromouracil and [6-¹²³I]iodouracil. Int. J. Appl. Radiat. Isot. 35, 531 (1984).10.1016/0020-708X(84)90176-5Suche in Google Scholar

244. Schaffland, A. O., Delaloye, A. B., Kosinski, M., Dupertuis, Y. M., Buchegger, F.: The preparation of clinical grade 5-[¹²³I]iodo-2′-deoxyuridine and 5-[¹²⁵I]iodo-2′-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy. Nucl. Med. Commun. 25(5), 461 (2004).10.1097/00006231-200405000-00006Suche in Google Scholar PubMed

245. Blasberg, R. G., Roelcke, U., Weinreich, R., Beattie, B., von Ammon, K., Yonekawa, Y., Landolt, H., Guenther, I., Crompton, N. E., Vontobel, P., Missimer, J., Maguire, R. P., Koziorowski, J., Knust, E. J., Finn, R. D., Leenders, K. L.: Imaging brain tumor proliferative activity with [¹²⁴I]iododeoxyuridine. Cancer Res. 60(3), 624 (2000).Suche in Google Scholar

246. Reske, S. N., Deisenhofer, S., Glatting, G., Zlatopolskiy, B. D., Morgenroth, A., Vogg, A. T. J., Buck, A. K., Friesen, C.: I-123-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines. J. Nucl. Med. 48(6), 1000 (2007).10.2967/jnumed.107.040337Suche in Google Scholar PubMed

247. Robins, M. J., Manfredini, S., Wood, S. G., Wanklin, R. J., Rennie, B. A., Sacks, S. L.: Nucleic-acid related-compounds. 65. New syntheses of 1-(Beta-D-Arabinofuranosyl)-5(E)-(2-Iodovinyl)uracil (Ivarau) from vinylsilane precursors – radioiodine uptake as a marker for thymidine kinase positive herpes viral-infections. J. Med. Chem. 34(7), 2275 (1991).10.1021/jm00111a050Suche in Google Scholar PubMed

248. Wilbur, D. S., Hamlin, D. K., Srivastava, R. R., Burns, H. D.: Synthesis and radioiodination of N-Boc-p-(tri-n-Butylstannyl)-L-phenylalanine tetrafluorophenyl ester – preparation of a radiolabeled phenylalanine derivative for peptide-synthesis. Bioconjug. Chem. 4(6), 574 (1993).10.1021/bc00024a024Suche in Google Scholar PubMed

249. Israel, I., Brandau, W., Farmakis, G., Samnick, S.: Improved synthesis of no-carrier-added p-[(124) I]iodo-L-phenylalanine and p-[I-131]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas. Appl. Radiat. Isot. 66(4), 513 (2008).10.1016/j.apradiso.2007.10.004Suche in Google Scholar PubMed

250. Knust, E. J., Dutschka, K., Machulla, H. J.: Radiopharmaceutical preparation of 3-¹²³I-alpha-methyltyrosine for nuclear-medical applications. J. Radioanal. Nucl. Chem. 144(2), 107 (1990).10.1007/BF02162193Suche in Google Scholar

251. Kloster, G., Coenen, H. H., Szabo, Z., Ritzl, F., Stöcklin, G.: Radiohalogenated L-α-methyltyrosines as potential pancreas imaging agents for PECT and SPECT. Progress in Radiopharmacology. Developments in Nuclear Medicine, volume 3, Springer, Dordrecht. p. 97 (1982).10.1007/978-94-009-7669-6_12Suche in Google Scholar

252. Biersack, H. J., Coenen, H. H., Stöcklin, G., Reichmann, K., Bockisch, A., Oehr, P., Kashab, M., Rollmann, O.: Imaging of brain tumors with L-3-[¹²³I]iodo-α-methyl tyrosine and SPECT. J. Nucl. Med. 30, 110 (1989).Suche in Google Scholar

253. Kloster, G., Laufer, P., Wutz, W., Stoecklin, G.: Bromine-75, bromine-77 and iodine-123 analogs of D-glucose as potential tracers for glucose utilization in heart and brain. Eur. J. Nucl. Med. 8(6), 237 (1983).10.1007/BF00522512Suche in Google Scholar PubMed

254. Kloster, G., Laufer, P., Stocklin, G.: D-glucose derivatives labeled with Br-75, Br-77 and I-123. J. Labelled Comp. Radiopharm. 20(3), 391 (1983).10.1002/jlcr.2580200309Suche in Google Scholar

255. Mccarter, J. D., Adam, M. J., Withers, S. G.: Syntheses, Radiolabeling, and kinetic evaluation of 2-deoxy-2-fluoro-2-iodo-d-hexoses for medical imaging. Carbohyd. Res. 266(2), 273 (1995).10.1016/0008-6215(94)00271-GSuche in Google Scholar

256. Lutz, T., Dougan, H., Rihela, T., Vo, C. V., Lyster, D. M.: ¹²³I-Iodobenzoylglucosamines: glucose analogues for heart imaging. J. Labelled Comp. Radiopharm. 33, 327 (1993).10.1002/jlcr.2580330411Suche in Google Scholar

257. Eakins, M. N., Waters, S. L.: The synthesis of ⁷⁷Br-labelled 5a-dihydrotestosterone and a comparison of its distribution in rats with ⁷⁷Br-bromide. Int. J. Appl. Radiat. Isot. 30, 701 (1979).10.1016/0020-708X(79)90112-1Suche in Google Scholar

258. Mason, N. S., Smith, H. E., Danzo, B. J., Clanton, J. A.: Synthesis of 17α-[¹²⁵I]iodoethynyl-4,6-androstadien-17β-Ol-3-One, and active-site-directed photoaffinity radiolabel for androgen-binding proteins. J. Labelled Comp. Radiopharm. 31, 729 (1992).10.1002/jlcr.2580311002Suche in Google Scholar

259. Downer, J. B., Jones, L. A., Engelbach, J. A., Lich, L. L., Mao, W., Carlson, K. E., Katzenellenbogen, J. A., Welch, M. J.: Comparison of animal models for the evaluation of radiolabeled androgens. Nucl. Med. Biol. 28(6), 613 (2001).10.1016/S0969-8051(01)00229-3Suche in Google Scholar

260. Labaree, D. C., Brown, T. J., Hoyte, R. M., Hochberg, R. B.: 7α-iodine-125-iodo-5α-dihydrotestosterone: a radiolabeled ligand for the androgen receptor. J. Nucl. Med. 38, 402 (1997).Suche in Google Scholar

261. Van Dort, M. E., Robins, D. M., Wayburn, B.: Design, synthesis, and pharmacological characterization of 4-[4,4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]-2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand. J. Med. Chem. 43(17), 3344 (2000).10.1021/jm000163ySuche in Google Scholar

262. Van Dort, M. E., Jung, Y-W., Sherman, P. S., Kuszpit, K. K.: Development of radioiodinated nonsteroidal androgen receptor ligands for SPECT imaging of prostate cancer. J. Labl. Comp. Radiopharm. 44 (Suppl. 1), S237 (2001).10.1002/jlcr.25804401115Suche in Google Scholar

263. Parent, E. E., Jenks, C., Sharp, T., Welch, M. J., Katzenellenbogen, J. A.: Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[Br-76]bromo-hydroxyflutamide. Nucl. Med. Biol. 33(6), 705 (2006).10.1016/j.nucmedbio.2006.05.009Suche in Google Scholar

264. Katzenellenbogen, J. A., McElvany, K. D., Senderoff, S. G., Carlson, K. E., Landvatter, S. W., Welch, M. J.: 16α-[⁷⁷Br]bromo-11β-methoxyestradiol-17β: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs. J. Nucl. Med. 23, 411 (1982).Suche in Google Scholar

265. Gibson, R. E., Eckelman, W. C., Francis, B., O’Brien, H. A., Mazaitis, J. K., Wilbur, S., Reba, R. C.: [⁷⁷Br]-17α-Bromoethynylestradiol: in vivo and in vitro characterization of an estrogen receptor radiotracer. Int. J. Nucl. Med. Biol. 9, 245 (1982).10.1016/0047-0740(82)90084-5Suche in Google Scholar

266. Hylarides, M. D., Leon, A. A., Mettler, F. A., Wilbur, D. S.: Radiolabeling of b- and c-ring of estradiol using no-carrier-added bromine-77. J. Labelled Comp. Radiopharm. 22, 443 (1985).10.1002/jlcr.2580220505Suche in Google Scholar

267. Hanson, R. N., El-Wakil, Murphy, F., Wilbur, D. S.: Synthesis and evaluation of ⁸²Br and ⁷⁷Br labeled (17, 20E)-21-bromo-19-norprena-1,3,5(10),20-tetraene-3,17-diol. J. Labelled Comp. Radiopharm. 27, 615 (1989).10.1002/jlcr.2580270602Suche in Google Scholar

268. Symes, E. K., Coulson, W. F., Das, R., Scurr, J. H. The synthesis of E-17-alpha-[I-131]iodo-vinyl estradiol and evaluation of its use as a radiotracer for estrogen-receptor positive breast-tumors. J. Steroid Biochem. 35(6), 641 (1990).10.1016/0022-4731(90)90303-ASuche in Google Scholar

269. Seevers, R. H., Mease, R. C., Friedman, A. M., Desombre, E. R.: The synthesis of non-steroidal estrogen receptor binding compounds labeled with ^80mBr. Nucl. Med. Biol. 13, 483 (1986).10.1016/0883-2897(86)90029-2Suche in Google Scholar

270. Zhou, D., Sharp, T. L., Fettig, N. M., Lee, H., Lewis, J. S., Katzenellenbogen, J. A., Welch, M. J. Evaluation of a bromine-76-labeled progestin 16 alpha,17 alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies. Nucl. Med. Biol. 35(6), 655 (2008).10.1016/j.nucmedbio.2008.05.001Suche in Google Scholar PubMed PubMed Central

271. Scott, A. M., Wolchok, J. D., Old, L. J.: Antibody therapy of cancer. Nat. Rev. Cancer 12(4), 278 (2012).10.1038/nrc3236Suche in Google Scholar PubMed

272. Adams, G. P., Weiner, L. M.: Monoclonal antibody therapy of cancer. Nat. Biotechnol. 23(9), 1147 (2005).10.1038/nbt1137Suche in Google Scholar PubMed

273. Stern, M., Herrmann, R.: Overview of monoclonal antibodies in cancer therapy: present and promise. Crit. Rev. Oncol. Hematol. 54(1), 11 (2005).10.1016/j.critrevonc.2004.10.011Suche in Google Scholar PubMed

274. Steiner, M., Neri, D.: Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends. Clin. Cancer Res. 17(20), 6406 (2011).10.1158/1078-0432.CCR-11-0483Suche in Google Scholar PubMed

275. von Mehren, M., Adams, G. P., Weiner, L. M.: Monoclonal antibody therapy for cancer. Annu. Rev. Med. 54, 343 (2003).10.1146/annurev.med.54.101601.152442Suche in Google Scholar PubMed

276. Sharkey, R. M., Goldenberg, D. M.: Targeted therapy of cancer: new prospects for antibodies and immunoconjugates. CA Cancer J. Clin. 56(4), 226 (2006).10.3322/canjclin.56.4.226Suche in Google Scholar PubMed

277. Lofblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Stahl, S., Frejd, F. Y.: Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett. 584(12), 2670 (2010).10.1016/j.febslet.2010.04.014Suche in Google Scholar

278. Zalutsky, M. R., Garg, P. K., Narula, A. S.: Labeling monoclonal antibodies with halogen nuclides. Acta Radiol. Suppl. 374, 141 (1990).Suche in Google Scholar

279. Eckelman, W. C., Paik, C. H., Reba, R. C.: Radiolabeling of antibodies. Cancer Res. 40, 3036 (1980).Suche in Google Scholar

280. Sands, H., Jones, P. L.: Methods for the study of the metabolism of radiolabeled monoclonal antibodies by liver and tumor. J. Nucl. Med. 28, 390 (1987).Suche in Google Scholar

281. Goldsmith, S. J.: Radioimmunotherapy of lymphoma: bexxar and zevalin. Semin. Nucl. Med. 40(2), 122 (2010).10.1053/j.semnuclmed.2009.11.002Suche in Google Scholar

282. Badger, C. C., Davis, J., Nourigat, C., Wu, Z. M., Hui, T. E., Fisher, D. R., Shulman, H., Appelbaum, F. R., Eary, J. F., Krohn, K. A., Matthews, D. C., Bernstein, I. D.: Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of ¹³¹I. Cancer Res. 51, 5921 (1991).Suche in Google Scholar

283. Carrasquillo, J. A., Pandit-Taskar, N., O’Donoghue, J. A., Humm, J. L., Zanzonico, P., Smith-Jones, P. M., Divgi, C. R., Pryma, D. A., Ruan, S., Kemeny, N. E., Fong, Y., Wong, D., Jaggi, J. S., Scheinberg, D. A., Gonen, M., Panageas, K. S., Ritter, G., Jungbluth, A. A., Old, L. J., Larson, S. M.: ¹²⁴I-huA33 antibody PET of colorectal cancer. J. Nucl. Med. 52(8), 1173 (2011).10.2967/jnumed.110.086165Suche in Google Scholar

284. Kalofonos, H. P., Pawlikowska, T. R., Hemingway, A., Courtenay-Luck, N., Dhokia, B., Snook, D., Sivolapenko, G. B., Hooker, G. R., McKenzie, C. G., Lavender, P. J.: Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J. Nucl. Med. 30, 1636 (1989).Suche in Google Scholar

285. Rossin, R., Berndorff, D., Friebe, M., Dinkelborg, L. M., Welch, M. J.: Small-animal PET of tumor angiogenesis using a Br-76-labeled human recombinant antibody fragment to the ED-B domain of fibronectin. J. Nucl. Med. 48(7), 1172 (2007).10.2967/jnumed.107.040477Suche in Google Scholar

286. Glaser, M., Carroll, V. A., Collingridge, D. R., Aboagye, E. O., Price, P., Bicknell, R., A. L. Harris, S. K. Luthra, F. Brady.: Preparation of the iodine-124 derivative of the Bolton-Hunter reagent ([I-124]I-SHPP) and its use for labelling a VEGF antibody as a PET tracer. J. Labelled Comp. Radiopharm. 45(12), 1077 (2002).10.1002/jlcr.634Suche in Google Scholar

287. Zalutsky, M. R., Narula, A. S.: A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Int. J. Rad. Appl. Instrum. Part A, Appl. Radiat. Isot. 38(12), 1051 (1987).10.1016/0883-2889(87)90069-4Suche in Google Scholar

288. Zalutsky, M. R., Narula, A. S.: Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(Tri-n-butylstannyl)benzoate intermediate. Cancer Res. 48, 1446 (1988).10.1016/0883-2889(88)90176-1Suche in Google Scholar

289. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., Fritzberg, A. R.: Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med. 30(2), 216 (1989).Suche in Google Scholar

290. Tolmachev, V., Orlova, A., Lundqvist, H.: Optimization of iodination of [¹²⁵I]-N-succinimidyl-para-iodobenzoate using Chloramine-T for labeling of proteins. J. Radioanal. Nucl. Chem. 246(1), 207 (2000).10.1023/A:1006755103374Suche in Google Scholar

291. Reist, C. J., Garg, P. K., Alston, K. L., Bigner, D. D., Zalutsky, M. R.: Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Cancer Res. 56(21), 4970 (1996).Suche in Google Scholar

292. Wilbur, D. S., Hylarides, M. D.: Radiolabeling of a monoclonal antibody with N-succinimidyl p-[⁷⁷Br]bromobenzoate. Nucl. Med. Biol. 18(3), 363 (1991).10.1016/0883-2897(91)90133-6Suche in Google Scholar

293. Ram, S., Buchsbaum, D. J.: Radioiodination of monoclonal antibodies D612 and 17-1A with 3-iodophenylisothiocyanate and their biodistribution in tumor-bearing nude mice. Cancer 73, 808 (1994).10.1002/1097-0142(19940201)73:3+<808::AID-CNCR2820731310>3.0.CO;2-RSuche in Google Scholar

294. Hylarides, M. D., Wilbur, D. S., Reed, M. W., Hadley, S. W., Schroeder, J. R., Grant, L. M.: Preparation and in vivo evaluation of an N-(p-[¹²⁵I]iodophenethyl)maleimide-antibody conjugate. Bioconjug. Chem. 2(6), 435 (1991).10.1021/bc00012a010Suche in Google Scholar

295. Srivastava, P. C., Buchsbaum, D. J., Allred, J. F., Brubaker, P. G., Hanna, D. E., Spicker, J. K.: A new conjugating agent for radioiodination of proteins: low in vivo deiodination of a radiolabeled antibody in a tumor model. Biotech. 8, 536 (1990).Suche in Google Scholar

296. Khawli, L. A., Van Den Abbeele, A. D., Kassis, A. I.: N-(m-[¹²⁵I]Iodophenyl)maleimide: an agent for high yield radiolabeling of antibodies. Nucl. Med. Biol. 19, 289 (1992).10.1016/0883-2897(92)90113-DSuche in Google Scholar

297. Kurth, M., Pèligrin, A., Rose, K., Offord, R. E., Pochon, S., Mach, J-P, Buchegger, F.: Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor. J. Med. Chem. 36, 1255 (1993).10.1021/jm00061a017Suche in Google Scholar PubMed

298. Paxton, R. J., Beatty, B. G., Varadarajan, A., Hawthorne, M. F.: Carboranyl peptide-antibody conjugates for neutron-capture therapy: preparation, characterization, and in vivo evaluation. Bioconjug. Chem. 3, 241 (1992).10.1021/bc00015a007Suche in Google Scholar PubMed

299. Winberg, K. J., Persson, M., Malmstrom, P-U., Sjoeberg, S., Tolmachev, V.: Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [⁷⁶Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion. Nucl. Med. Biol. 31(4) 425 (2004).10.1016/j.nucmedbio.2003.11.007Suche in Google Scholar PubMed

300. Nestor, M., Persson, M., Cheng, J., Tolmachev, V., Van Dongen, G., Anniko, M., Kairemo, K.: Biodistribution of the Chimeric Monoclonal Antibody U36 Radioiodinated with a closo-Dodecaborate-Containing Linker. Comparison with Other Radioiodination Methods. Bioconjug. Chem. 14(4), 805 (2003).10.1021/bc034003nSuche in Google Scholar PubMed

301. Bruskin, A., Sivaev, I., Persson, M., Lundqvist, H., Carlsson, J., Sjoberg, S., Tolmachev, V.: Radiobromination of monoclonal antibody using potassium [⁷⁶Br] (4-isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI). Nucl. Med. Biol. 31(2), 205 (2004).10.1016/j.nucmedbio.2003.08.005Suche in Google Scholar PubMed

302. Wilbur, D. S., Chyan, M. K., Hamlin, D. K., Vessella, R. L., Wedge, T. J., Hawthorne, M. F.: Reagents for astatination of biomolecules. 2. conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Bioconjug. Chem. 18(4), 1226 (2007).10.1021/bc060345sSuche in Google Scholar PubMed

303. Wilbur, D. S., Chyan, M. K., Hamlin, D. K., Perry, M. A.: Reagents for astatination of biomolecules. 3. comparison of closo-Decaborate(2-) and closo-Dodecaborate(2-) moieties as reactive groups for labeling with astatine-211. Bioconjug. Chem. 20(3), 591 (2009).10.1021/bc800515dSuche in Google Scholar PubMed PubMed Central

304. Wilbur, D. S., Chyan, M. K., Nakamae, H., Chen, Y., Hamlin, D. K., Santos, E. B., Kornblit, B. T., Sandmaier, B. M. Reagents for astatination of biomolecules. 6. an intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines. Bioconjug. Chem. 23(3), 409 (2012).10.1021/bc200401bSuche in Google Scholar PubMed PubMed Central

305. Bolton, A. E., Hunter, W. M.: The labelling of proteins to high specific radioactivities by conjugation to a ¹²⁵I-containing acylating agent. Biochem. J. 133, 529 (1973).10.1042/bj1330529Suche in Google Scholar PubMed PubMed Central

306. Lucka, B., Siuda, A.: Preparation of bolton and hunter’s reagent for labelling proteins with iodine-125. J. Labelled Comp. Radiopharm. 15, 495 (1978).10.1002/jlcr.2580150156Suche in Google Scholar

307. Garg, P. K., Slade, S. K., Harrison, C. L., Zalutsky, M. R.: Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability. Int. J. Rad. Appl. Instrum B 16(7), 669 (1989).10.1016/0883-2897(89)90136-0Suche in Google Scholar

308. Wilbur, D. S., Hadley, S. W., Grant, L. M., Hylarides, M. D.: Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab. Bioconjug. Chem. 2(2), 111 (1991).10.1021/bc00008a006Suche in Google Scholar PubMed

309. Gifford, A. N., Kuschel, S., Shea, C., Fowler, J. S.: Polymer-supported organotin reagent for prosthetic group labeling of biological macromolecules with radioiodine. Bioconjug. Chem. 22(3), 406 (2011).10.1021/bc1004203Suche in Google Scholar PubMed

310. Donovan, A. C., Valliant, J. F.: Preparation and evaluation of reagents for tagging amino and thiol groups with fluorous stannanes. A convenient method for producing radioiodinated compounds in high effective specific activity. J. Labelled Comp. Radiopharm. 54(2), 65 (2011).10.1002/jlcr.1807Suche in Google Scholar

311. Hawthorne, M. F., Maderna, A.: Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer. Chem. Rev. 99(12), 3421 (1999).10.1021/cr980442hSuche in Google Scholar PubMed

312. Armstrong, A. F., Valliant, J. F.: The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. Dalton T. (38) 4240 (2007).10.1039/b709843jSuche in Google Scholar PubMed

313. Morgat, C., Mishra, A. K., Varshney, R., Allard, M., Fernandez, P., Hindie, E.: Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-y receptors. J. Nucl. Med. 55(10), 1650 (2014).10.2967/jnumed.114.142000Suche in Google Scholar PubMed

314. Fani, M., Maecke, H. R.: Radiopharmaceutical development of radiolabelled peptides. Eur. J. Nucl. Med. Mol. I. 39, 11 (2012).10.1007/s00259-011-2001-zSuche in Google Scholar PubMed

315. Forrer, F., Valkema, R., Kwekkeboom, D. J., de Jong, M., Krenning, E. P.: Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best. Pract. Res. Clin. Endocrinol. Metab. 21(1), 111 (2007).10.1007/978-3-030-17494-1_4Suche in Google Scholar

316. Weiner, R. E., Thakur, M. L.: Radiolabeled peptides in oncology: role in diagnosis and treatment. BioDrugs 19(3), 145 (2005).10.2165/00063030-200519030-00002Suche in Google Scholar PubMed

317. Gaertner, F. C., Kessler, H., Wester, H. J., Schwaiger, M., Beer, A. J.: Radiolabelled RGD peptides for imaging and therapy. Eur. J. Nucl. Med. Mol. Imaging 39, 126 (2012).10.1007/s00259-011-2028-1Suche in Google Scholar PubMed

318. Schottelius, M., Wester, H-J., Reubi Jean, C., Senekowitsch-Schmidtke, R., Schwaiger, M.: Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates. Bioconjug. Chem. 13(5), 1021 (2002).10.1021/bc0200069Suche in Google Scholar PubMed

319. Breslav, M., McKinney, A., Becker, J. M., Naider, F.: Preparation of radiolabeled peptides via an iodine exchange reaction. Anal. Biochem. 239, 213 (1996).10.1006/abio.1996.0317Suche in Google Scholar PubMed

320. Ceusters, M., Tourwe, D., Callaerts, J., Mertens, J., Peter, A.: New single-step radioiodination technique for peptides: Cu(I)-catalyzed nucleophilic nonisotopic displacement reaction. Synthesis of radioiodinated deltorphin and dermorphin analogues. J. Organ Chem. 60(25), 8324 (1995).10.1021/jo00130a041Suche in Google Scholar

321. Crim, J. W., Garczynski, S. F., Brown, M. R.: Approaches to radioiodination of insect neuropeptides. Peptides (New York, NY, United States) 23(11), 2045 (2002).10.1016/S0196-9781(02)00192-4Suche in Google Scholar

322. Garg, P. K., Alston, K. L., Welsh, P. C., Zalutsky, M. R.: Enhanced binding and inertness to dehalogenation of α-melanotropic peptides labeled using N-Succinimidyl 3-Iodobenzoate. Bioconjug. Chem. 7, 233 (1996).10.1021/bc960001+Suche in Google Scholar PubMed

323. Reist, C. J., Archer, G. E., Wikstrand, C. J., Bigner, D. D., Zalutsky, M. R.: Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Cancer Res. 57(8), 1510 (1997).Suche in Google Scholar

324. Sharma, S. D., Toth, G., Hruby, H. V.: A simple general method for (radio)iodination of a phenylalanine residue in peptides: preparation of [D-Pen2,4′-¹²⁵I-Phe4, D-Pen5]enkephalin, a peptide with extraordinary selectivity for ∂-opioid receptors. J. Organ Chem. 56, 4981 (1991).10.1021/jo00016a035Suche in Google Scholar

325. Virgolini, I., Angelberger, P., Li, S., Yang, Q., Kurtaran, A., Raderer, M., Neuhold, N., Kaserer, K., Leimer, M., Peck-Radosavljevic, M., Scheithauer, W., Niederle, B., Eichler, H. G., Valent, P.: In vitro and in vivo studies of three radiolabelled somatostatin analogues: ¹²³I-octreotide (OCT), ¹²³I-Tyr-3-OCT and ¹¹¹In-DTPA-D-Phe-1-OCT. Eur. J. Nucl. Med. 23, 1388 (1996).10.1007/BF01367597Suche in Google Scholar PubMed

326. Carnazzi, E., Aumelas, A., Mouillac, B., Breton, C., Guillou, L., Barberis, C., Seyer, R.: Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist. J. Med. Chem. 44(18), 3022 (2001).10.1021/jm010125uSuche in Google Scholar PubMed

327. Cheng, Z., Chen, J. Q., Quinn, T. P., Jurisson, S. S.: Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma. Cancer Res. 64(4), 1411 (2004).10.1158/0008-5472.CAN-03-0193Suche in Google Scholar